Clinical Trial Update: Wearables-and Blood-based Biomarkers-incorporated Modernisation of Circadian Rhythm Disruption Management in People Living With Alzheimer's Dementia: A Stepwise Study From Digital Inclusivity, Digital Therapy, to Digital Phenotyping and Biomarker Exploration [NA]

View source ↗

Summary

This clinical trial investigates wearables and blood-based biomarkers to modernize management of circadian rhythm disruption in Alzheimer's disease, using digit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: China Medical University Hospital | Conditions: Alzheimer Disease | NA | Status: NOT_YET_RECRUITING